Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ligand discovery and virtual screening using the program LIDAEUS.

P Taylor1, E Blackburn, Y G Sheng

  • 1The Centre for Translational and Chemical Biology, The University of Edinburgh, Michael Swann Building, King's Buildings, Mayfield Road, Edinburgh, UK.

British Journal of Pharmacology
|November 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Characteristic Contributions to the Superconducting State of 2H-NbSe_{2}.

Physical review letters·2025
Same author

Inter- and Intrasublattice Spin Mixing Conductance of the Antiferromagnetic Spin Pumping Effect in α-Fe_{2}O_{3}/Pt.

Physical review letters·2025
Same author

The fluctuation-dissipation measurement instrument at the Linac Coherent Light Source.

The Review of scientific instruments·2022
Same author

Spatially inhomogeneous competition between superconductivity and the charge density wave in YBa<sub>2</sub>Cu<sub>3</sub>O<sub>6.67</sub>.

Nature communications·2020
Same author

Quantitative Characterization of the Nanoscale Local Lattice Strain Induced by Sr Dopants in La_{1.92}Sr_{0.08}CuO_{4}.

Physical review letters·2018
Same author

Shorter preschool, leukocyte telomere length is associated with obesity at age 9 in Latino children.

Clinical obesity·2017
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
Same journal

The role of protein arginine methyltransferases in sickle cell-mediated neurovascular impairments in mice.

British journal of pharmacology·2026
Same journal

β-Cyclodextrin inclusion enhances the pro-resolving effects of the annexin A1 mimetic Ac2-26 in a mouse model of antigen-induced arthritis.

British journal of pharmacology·2026
See all related articles

This study advances molecular docking and virtual screening methods, leading to the discovery of novel inhibitors for key targets like CypA and CDK2. These findings highlight the power of computational approaches in drug discovery.

Area of Science:

  • Computational chemistry and drug discovery.
  • Development of novel small molecule therapeutics.

Background:

  • High-throughput virtual screening (HTVS) is crucial for identifying drug candidates.
  • Advances in computational power and database development are enabling more sophisticated screening methods.

Purpose of the Study:

  • To present advances in docking and scoring methodologies for drug discovery.
  • To showcase the application of the LIDAEUS program in identifying small molecule inhibitors.

Main Methods:

  • Utilized the LIDAEUS high-throughput virtual screening program.
  • Employed advanced docking and scoring algorithms.
  • Leveraged massively parallel computing and annotated databases.

Main Results:

Related Experiment Videos

  • Successfully discovered small molecule inhibitors for immunophilin CypA.
  • Identified inhibitors for the cyclin-dependent kinase CDK2.
  • Developed cyclapolin series inhibitors targeting Polo-like kinase.

Conclusions:

  • The developed docking and scoring approaches are effective for identifying potent inhibitors.
  • Computational drug discovery, powered by advanced computing and databases, shows significant promise.
  • The identified inhibitors represent potential leads for therapeutic development.